Rophibio Inc.

About Rophibio Inc.

Rophibio Inc. - Biosimilar Development Company 

Platform Technologies - Cell Line Development Platform 


Location - South Korea 


Global Phase 3 CT ongoing for Rophibio's Aflibercept biosimilar


Looking for potential L/O Opportunities, Codevelopment, and/or Long-Term Strategic Partnerships

  • KR
  • 2023
    On CPHI since
  • 1 - 24
    Employees
Company types
Biopharmaceutical company
Primary activities
Biopharmaceutical
Contact info
  • 6th FL, 33 Research Complex-ro 55 beon-gil, Yeonsu-gu, Incheon, South Korea 21984, 21984, Yeonsu-gu, Incheon, Korea, Republic Of